HemaCare Co. (OTCMKTS:HEMA – Get Free Report) traded up 0.6% during mid-day trading on Monday . The company traded as high as $25.31 and last traded at $25.31. 5,400 shares traded hands during mid-day trading, a decline of 86% from the average session volume of 39,950 shares. The stock had previously closed at $25.16.
HemaCare Stock Performance
The business has a 50-day moving average price of $25.31 and a 200-day moving average price of $25.31.
HemaCare Company Profile
HemaCare Corporation provides human-derived primary blood cells and tissues for biomedical research, and supporting cell therapy clinical trials and commercialization with apheresis collections in the United States. The company specializes in the customized collection, isolation, and testing of primary human blood cells and other biological products for research protocols and cellular therapy.
See Also
- Five stocks we like better than HemaCare
- Which Wall Street Analysts are the Most Accurate?
- Autodesk Stock: Analysts’ Top AI Pick You Shouldn’t Overlook
- How to Calculate Retirement Income: MarketBeat’s Calculator
- Hidden Opportunities in Li Auto’s Tough Quarter You Can’t Miss
- How to Read Stock Charts for Beginners
- Don’t Overlook Campbell Soup: Here’s What Could Drive Its Stock
Receive News & Ratings for HemaCare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HemaCare and related companies with MarketBeat.com's FREE daily email newsletter.
